McGill University Health Center, Montreal, Quebec, Canada.
Ann Pharmacother. 2012 Sep;46(9):1167-73. doi: 10.1345/aph.1R180. Epub 2012 Aug 28.
The involvement of Canadian critical care pharmacists in clinical research is not well documented.
To describe the clinical research experience of Canadian critical care pharmacists, describe their views about clinical research, and identify factors that facilitate their involvement in clinical research.
A cross-sectional electronic survey of Canadian critical care pharmacists was developed through an iterative process and conducted from July to October 2010. We invited 325 pharmacists from 129 hospitals across Canada to participate. Surveys with more than 30% of questions unanswered were discarded.
Analyzable response rate was 66.2%. Overall, 33 pharmacists (15.7%) were highly involved in research, 54 (25.7%) were moderately involved, and 123 (58.6%) were minimally involved. Most respondents (97.2%) believed that critical care pharmacist involvement in research was desirable, and many (80.4%) expressed interest to be more involved in research. Nearly all respondents (99.5%) agreed that more support should be provided to pharmacists interested in conducting research. Pharmacists currently involved in research have obtained higher academic degrees (adjusted OR 11.23; p < 0.001), express a strong interest in research (adjusted OR 7.44; p < 0.001), report a higher level of training for involvement in research (adjusted OR 2.23; p = 0.047), and practice more often in a university hospital (adjusted OR 3.68; p = 0.004) within an intensive care unit where involvement in research is valued (adjusted OR 5.61; p < 0.001). Support from pharmacy departments is not related to involvement in research (adjusted OR 1.22; p = 0.633).
Canadian critical care pharmacists are involved to varying degrees in clinical research and are very interested in initiating and supporting research activities. Opportunities are present but significant barriers exist. The value of pharmacist-initiated research needs recognition as a priority within hospital pharmacy administration.
加拿大重症监护药剂师参与临床研究的情况并未得到很好的记录。
描述加拿大重症监护药剂师的临床研究经验，描述他们对临床研究的看法，并确定促进他们参与临床研究的因素。
通过迭代过程开发了一项针对加拿大重症监护药剂师的横断面电子调查，并于 2010 年 7 月至 10 月进行。我们邀请了来自加拿大 129 家医院的 325 名药剂师参与。丢弃了超过 30%的问题未回答的调查。
可分析的响应率为 66.2%。总体而言，33 名药剂师（15.7%）高度参与研究，54 名（25.7%）中度参与，123 名（58.6%）低度参与。大多数受访者（97.2%）认为重症监护药剂师参与研究是可取的，许多人（80.4%）表示有兴趣更多地参与研究。几乎所有受访者（99.5%）都同意应该为有兴趣进行研究的药剂师提供更多支持。目前参与研究的药剂师获得了更高的学历（调整后的 OR 11.23；p < 0.001），对研究表现出强烈的兴趣（调整后的 OR 7.44；p < 0.001），报告了更高水平的培训以参与研究（调整后的 OR 2.23；p = 0.047），并且更经常在重视研究的重症监护病房的大学医院（调整后的 OR 3.68；p = 0.004）执业。来自药房部门的支持与参与研究无关（调整后的 OR 1.22；p = 0.633）。
加拿大重症监护药剂师以不同程度参与临床研究，对开展和支持研究活动非常感兴趣。机会存在，但存在重大障碍。药师发起的研究的价值需要作为医院药房管理的优先事项得到认可。
